These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 12744067)
1. [The morphofunctional state of the surfactant system in pulmonary tuberculosis]. Lepekha LN; Erokhin VV Probl Tuberk; 2003; (3):51-4. PubMed ID: 12744067 [No Abstract] [Full Text] [Related]
2. [The morphofunctional heterogeneity of the alveolar macrophages in disseminated pulmonary tuberculosis]. Erokhin VV; Lepekha LN; Nikolaeva GM Probl Tuberk; 1996; (1):51-6. PubMed ID: 8907490 [TBL] [Abstract][Full Text] [Related]
3. [Selective effects of pulmonary surfactant on various subpopulations of alveolar macrophages in the model of experimental tuberculosis]. Erokhin VV; Lepekha LN; Erokhina MV; Bocharova IV; Kurynina AV; Onishchenko GE Vestn Ross Akad Med Nauk; 2012; (11):22-8. PubMed ID: 23457977 [TBL] [Abstract][Full Text] [Related]
4. [Behavior of pulmonary surfactant in experimental tuberculosis in guinea pigs]. Traczyk K Pneumonol Pol; 1976 May; 44(5):445-61. PubMed ID: 946906 [No Abstract] [Full Text] [Related]
5. [Bronchoalveolar lavage in assessing the structural integrity of surfactant in pulmonary tuberculosis]. Erokhin VV; Filippenko LN Probl Tuberk; 1988; (8):38-41. PubMed ID: 3200813 [No Abstract] [Full Text] [Related]
6. [State of the surfactant in different forms of pulmonary tuberculosis]. Zagorul'ko AK; Birkun AA; Kobozev GV; Safronova LG Probl Tuberk; 1988; (2):58-62. PubMed ID: 3375221 [No Abstract] [Full Text] [Related]
7. Interactions between pulmonary surfactant and alveolar macrophages in the pathogenesis of lung disease. Yoshida M; Whitsett JA Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL639-48. PubMed ID: 15579257 [TBL] [Abstract][Full Text] [Related]
11. [Relationship of the surfactant level to the course of experimental pulmonary tuberculosis]. Agapov IuIa; Bondarev IM; Volkova NV; Novoselova VP Patol Fiziol Eksp Ter; 1976; (4):65-8. PubMed ID: 1036618 [No Abstract] [Full Text] [Related]
12. [Proteinases of alveolar macrophages and the liquid phase of bronchoalveolar washings in guinea pigs during the development of experimental tuberculosis]. Alieva LP Probl Tuberk; 1987; (11):60-4. PubMed ID: 3325977 [No Abstract] [Full Text] [Related]
13. [Surface-active properties of pulmonary surfactant in experimental pulmonary tuberculosis]. Bondarev IM; Agapov IuIa; Volkova NV Ter Arkh; 1975; 47(1):109-10. PubMed ID: 1172889 [No Abstract] [Full Text] [Related]
14. [Results of use of surfactant in complex therapy of patients with destructive pulmonary tuberculosis]. Lovacheva OV; Erokhin VV; Chernichenko NV; Evgushchenko GV; Lepekha LN; Rozenberg OA Probl Tuberk Bolezn Legk; 2006; (10):12-7. PubMed ID: 17139825 [TBL] [Abstract][Full Text] [Related]
15. [Effect of surfactant-BL on ventilation and gas exchange function in patients with destructive pulmonary tuberculosis]. Chernichenko NV; Shergina EA; Lovacheva OV; Erokhin VV Probl Tuberk Bolezn Legk; 2006; (6):6-10. PubMed ID: 16881226 [TBL] [Abstract][Full Text] [Related]
16. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres. Tomoda K; Kojima S; Kajimoto M; Watanabe D; Nakajima T; Makino K Colloids Surf B Biointerfaces; 2005 Sep; 45(1):1-6. PubMed ID: 16099143 [TBL] [Abstract][Full Text] [Related]